FindTrial
Sign In

Exploratory study for the law of Tongluo Shumu Decoction in the treatment of Aqueous deficient dry eye

Exploratory study for the law of Tongluo Shumu Decoction in the treatment of Aqueous deficient dry eye

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900022729
Enrollment
Unknown
Registered
2019-04-23
Start date
2019-05-02
Completion date
Unknown
Last updated
2019-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry eye

Interventions

1:Tongluo Shumu Decoction

Sponsors

Xiyuan Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Patients who are diagnosed with liver and kidney yin deficiency type of ADDE; (2) Patients who are receiving Tongluo Shumu Decoction; (3) Aged 18 to 70 years; (4) Sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) All patients suffering from diseases associated with dry eye, such as diabetes, Steven-Johnson syndrome, etc.; (2) A permanent punctum embolization or a degradable punctum embolization treatment within half a year; (3) Patients with severe primary diseases or mental illnesses such as heart, liver and kidney; (4) Patients who are participating in other clinical trials; (5) Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
BUT;TMH;Schirmer ? Test;Subjective symptom score;—

Countries

China

Contacts

Public ContactWanyu Zhou

Xiyuan Hospital, China Academy of Chinese Medical Sciences

zhouwylx@sina.com+86 010-62835138

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026